Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;25(4):461-5.
doi: 10.1038/eye.2011.9. Epub 2011 Feb 18.

Incidence of primary malignant orbital tumours in the Netherlands

J H Koopman  1 , M van der Heiden-van der Loo, M R van Dijk, W R Bijlsma
Affiliations

Incidence of primary malignant orbital tumours in the Netherlands

J H Koopman et al. Eye (Lond). 2011 Apr.

Abstract

Aims: To describe the incidence and relative frequencies of primary malignant orbital tumours in the Netherlands from 1989 to 2006.

Methods: All registered primary malignant orbital tumours were extracted from the population-based database of the Netherlands Cancer Registry. Age-adjusted incidence of malignant orbital tumours per 10,000,000 persons per year and the estimated annual percentage change (EAPC) were computed.

Results: A total of 367 malignant orbital tumours were registered. The average age-adjusted incidence of malignant orbital tumours is 10.9. Lymphoma has a relative frequency of 67%, rhabdomyosarcoma 12%, adenocarcinoma 6%, and adenoid cystic carcinoma 5%. The incidence of primary malignant orbital tumours has been increasing in the Netherlands (EAPC +2.8%).

Conclusion: In the Netherlands, lymphoma is the most common primary malignant orbital tumour, followed by rhabdomyosarcoma, adenocarcinoma, and adenoid cystic carcinoma. The relative frequencies of the different histological tumour types are comparable to the frequencies in other parts of the world. The incidence of malignant primary orbital tumours shows a slight increase between 1989 and 2006.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Age distribution among the three largest histological subgroups and the remaining primary malignant orbital tumours in the Netherlands from 1989 to 2006.
Figure 2
Figure 2
The course of primary malignant orbital tumour incidence (centred 3-year moving average) standardised to the world population (WSR) from 1989 to 2006.
See this image and copyright information in PMC

References

    1. van der Sanden GA, Coebergh JW, Schouten LJ, Visser O, van Leeuwen FE. Cancer incidence in the Netherlands in 1989 and 1990: first results of the nationwide netherlands cancer registry. Coordinating committee for regional cancer registries. Eur J Cancer. 1995;31A:1822–1829. - PubMed
    1. Margo CE, Mulla ZD. Malignant tumours of the orbit. Analysis of the florida cancer registry. Ophthalmology. 1998;105:185–190. - PubMed
    1. Lee SB, Au Eong KG, Saw SM, Chan TK, Lee HP. Eye cancer incidence in singapore. Br J Ophthalmol. 2000;84:767–770. - PMC - PubMed
    1. Cheng CY, Hsu WM. Incidence of eye cancer in taiwan: an 18-year review. Eye. 2004;18:152–158. - PubMed
    1. Casparie M, Tiebosch AT, Burger G, Blauwgeers H, van de Pol A, van Krieken JH, et al. Pathology databanking and biobanking in the netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol. 2007;29:19–24. - PMC - PubMed